Literature DB >> 10730114

Evaluating the return of prostatic adenocarcinoma.

M G Berry1, M R Feneley, P Domizio, K E Britton, D F Badenoch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 10730114      PMCID： PMC1296985          DOI： 10.1177/014107689809101209

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  4 in total

1.  Imaging prostate cancer with technetium-99m-7E11-C5.3 (CYT-351).

Authors:  V U Chengazi; M R Feneley; D Ellison; M Stalteri; A Granowski; M Granowska; C C Nimmon; S J Mather; R S Kirby; K E Britton
Journal:  J Nucl Med       Date:  1997-05       Impact factor: 10.057

2.  Prostatic radioimmunoscintigraphy: preliminary results using technetium-labelled monoclonal antibody, CYT-351.

Authors:  M R Feneley; V U Chengazi; R S Kirby; C C Nimmon; M Granowska; S J Mather; D Ellison; A R Granowski; K E Britton
Journal:  Br J Urol       Date:  1996-03

Review 3.  Correlative imaging with monoclonal antibodies in colorectal, ovarian, and prostate cancer.

Authors:  C E Neal; L C Meis
Journal:  Semin Nucl Med       Date:  1994-10       Impact factor: 4.446

4.  Minimal or no cancer in radical prostatectomy specimens. Report of 13 cases of the "vanishing cancer phenomenon".

Authors:  N S Goldstein; L R Bégin; W W Grody; J M Novak; J Qian; D G Bostwick
Journal:  Am J Surg Pathol       Date:  1995-09       Impact factor: 6.394
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.